Search Results - "Proudhon, Charlotte"
-
1
Circulating tumor cells: clinical validity and utility
Published in International journal of clinical oncology (01-06-2017)“…Circulating tumor cells (CTCs) are rare tumor cells and have been investigated as diagnostic, prognostic and predictive biomarkers in many types of cancer…”
Get full text
Journal Article -
2
Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Published in Clinical chemistry (Baltimore, Md.) (01-03-2017)“…In nonmetastatic triple-negative breast cancer (TNBC) patients, we investigated whether circulating tumor DNA (ctDNA) detection can reflect the tumor response…”
Get full text
Journal Article -
3
Circulating tumor cells in breast cancer
Published in Molecular oncology (01-03-2016)“…Over the past decade, technically reliable circulating tumor cell (CTC) detection methods allowed the collection of large datasets of CTC counts in cancer…”
Get full text
Journal Article -
4
A single droplet digital PCR for ESR1 activating mutations detection in plasma
Published in Oncogene (02-04-2020)“…Activating mutations in the estrogen receptor 1 ( ESR1 ) gene confer resistance to aromatase inhibitors (AI), and may be targeted by selective estrogen…”
Get full text
Journal Article -
5
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients
Published in Breast cancer research : BCR (06-03-2021)“…Following the PALOMA-3 study results, the combination of palbociclib, a CDK4/6 inhibitor, with fulvestrant, a selective estrogen receptor degrader, has become…”
Get full text
Journal Article -
6
Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial
Published in Clinical cancer research (01-04-2019)“…Human papillomavirus (HPV) is found in 90% of squamous cell carcinomas of the anal canal (SCCA). We investigated the clinical validity of HPV circulating tumor…”
Get full text
Journal Article -
7
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma
Published in Clinical cancer research (15-11-2018)“…Chemoradiotherapy (CRT) is the current standard of care for patients diagnosed with locally advanced anal squamous cell carcinoma (ASCC), but some patients…”
Get full text
Journal Article -
8
Circulating Tumor Cells in Early Breast Cancer
Published in JNCI cancer spectrum (01-06-2019)“…Circulating tumor cells (CTCs) are particularly rare in non-metastatic breast cancer, and the clinical validity of CTC detection in that clinical setting was…”
Get full text
Journal Article -
9
4C-ker: A Method to Reproducibly Identify Genome-Wide Interactions Captured by 4C-Seq Experiments
Published in PLoS computational biology (01-03-2016)“…4C-Seq has proven to be a powerful technique to identify genome-wide interactions with a single locus of interest (or "bait") that can be important for gene…”
Get full text
Journal Article -
10
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer
Published in NPJ breast cancer (09-09-2021)“…Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) are two cancer-derived blood biomarkers that inform on patient prognosis and treatment…”
Get full text
Journal Article -
11
Identification of multi-loci hubs from 4C-seq demonstrates the functional importance of simultaneous interactions
Published in Nucleic acids research (14-10-2016)“…Use of low resolution single cell DNA FISH and population based high resolution chromosome conformation capture techniques have highlighted the importance of…”
Get full text
Journal Article -
12
Protection against De Novo Methylation Is Instrumental in Maintaining Parent-of-Origin Methylation Inherited from the Gametes
Published in Molecular cell (28-09-2012)“…Identifying loci with parental differences in DNA methylation is key to unraveling parent-of-origin phenotypes. By conducting a MeDIP-Seq screen…”
Get full text
Journal Article -
13
Quantifying HER-2 expression on circulating tumor cells by ACCEPT
Published in PloS one (30-10-2017)“…Circulating tumor cells (CTCs) isolated from blood can be probed for the expression of treatment targets. Immunofluorescence is often used for both the…”
Get full text
Journal Article -
14
Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer
Published in Molecular oncology (01-03-2016)“…Pancreatic ductal adenocarcinoma (PDAC) is the most frequent pancreatic cancer type and is characterized by a dismal prognosis due to late diagnosis, local…”
Get full text
Journal Article -
15
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial
Published in Cells (Basel, Switzerland) (28-05-2019)“…The management of patients with colorectal cancer (CRC) and potentially resectable liver metastases (LM) requires quick assessment of mutational status and of…”
Get full text
Journal Article -
16
Active and Inactive Enhancers Cooperate to Exert Localized and Long-Range Control of Gene Regulation
Published in Cell reports (Cambridge) (07-06-2016)“…V(D)J recombination relies on the presence of proximal enhancers that activate the antigen receptor (AgR) loci in a lineage- and stage-specific manner…”
Get full text
Journal Article -
17
The parental non-equivalence of imprinting control regions during mammalian development and evolution
Published in PLoS genetics (01-11-2010)“…In mammals, imprinted gene expression results from the sex-specific methylation of imprinted control regions (ICRs) in the parental germlines. Imprinting is…”
Get full text
Journal Article -
18
Circulating extracellular vesicles provide valuable protein, but not DNA, biomarkers in metastatic breast cancer
Published in Journal of extracellular biology (01-07-2022)“…Detection of cell‐free circulating tumour DNA (ctDNA) and cancer‐specific extracellular vesicles (EVs) in patient blood have been widely explored as…”
Get full text
Journal Article -
19
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy
Published in Nature reviews. Clinical oncology (01-10-2018)“…Considerable interest surrounds the use of immune-checkpoint inhibitors in patients with solid tumours following the demonstration of the impressive clinical…”
Get full text
Journal Article -
20
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
Published in JNCI : Journal of the National Cancer Institute (01-06-2018)“…Abstract Background We conducted a meta-analysis in nonmetastatic breast cancer patients treated by neoadjuvant chemotherapy (NCT) to assess the clinical…”
Get full text
Journal Article